In 2021, the M&A market recovered from the first corona crisis year. Despite new uncertainties in the world, intensive merger control will continue in 2022. Read more >
The Commission and ACM remain critical of pharma and big tech companies. In this blog we address the developments regarding the prohibition on abuse of dominant positions. Read more >
A new era is dawning in the agri-food sector. ACM has been given a new enforcement instrument to take action against the purchasing power of retailers, and the sector will have more opportunities for sustainability initiatives. Read more >
The new Vertical Block Exemption Regulation will enter into force on 1 June 2022. This blog addresses the main changes for franchise agreements. Read more >
The NZa merger test was and remains superfluous. The NZa and ACM would be better advised to focus on real problems in the healthcare sector. Read more >